BNB fell more than 4.5% in the last 24 hours, dropping from around $805.7 to $766 at the time of writing as investors move away from risk assets as U.S. interest-rate cut hopes faded.
The selling accelerated near $803, where a surge in trading volume, roughly 56% above average, marked a turning point, according to CoinDesk Research’s technical analysis model. BNB sank sharply from there, slicing through short-term support zones near $789 and $777.
Overnight, the $767 level emerged as a key battleground, absorbing heavy sell orders and stalling the decline. Despite a small bounce toward $769, buying momentum faded quickly.
The drop comes as President Donald Trump’s tariffs start to take effect, with some kicking in today and others on Aug. 7. These tariffs saw the U.S. dollar index rise above 100 for the first time since May.
Adding to the stronger dollar, interest rates may remain higher for longer. The Federal Reserve’s preferred inflation measure, the core PCE, rose 2.8% year-over-year in June, damping hopes for a rate cut in September.
The BNB slide mirrors the larger crypto landscape, with the CoinDesk 20 (CD20) index dropping 5.8% in the past 24 hours.
The cryptocurrency is nevertheless seeing growing corporate adoption. CEA Industries (VAPE), backed by Binance co-founder Changpeng Zhao’s family office, Yzi Labs, announced plans to raise up to $1.2 billion to build what it called the largest U.S.-listed BNB treasury.
They aren’t alone. Liminatus Pharma (LIMN), a clinical-stage biopharma firm, launched a BNB investment arm with a $500 million funding goal. Windtree Therapeutics (WINT) disclosed a $700 million BNB acquisition strategy, while Nano Labs reported buying 128,000 BNB as part of its new crypto treasury plan.
Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk’s full AI Policy.